• Profile
Close

Overexpression of ARID4B predicts poor survival in patients with hepatocellular carcinoma

Human Pathology Jan 05, 2018

Wang R, et al. - This study was conducted to determine whether or not overexpression of AT-rich interaction domain 4B (ARID4B) predicted poor survival in patients with hepatocellular carcinoma (HCC). ARID4B was shown to act as an oncogene in HCC. Therefore, it could serve as a biomarker for the prognoses of patients with HCC.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay